Error: Could not add to watchlist. X
+ Watchlist

BB Adamant Global Biotech

ADGLBII:SW
2,753.10
CHF
0.56
0.02%
As of 9:04 AM EDT 7/26/2016
Fund Type
Open-End Fund
52Wk Range
2,327.82 - 4,038.80
1 Yr Return
-30.13%
YTD Return
-23.74%
Previous Close
2,752.54
52Wk Range
2,327.82 - 4,038.80
1 Yr Return
-29.11%
YTD Return
-23.74%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 07/26/2016)
2,753.1
Total Assets (m CHF) (on 07/26/2016)
120.021
Inception Date
10/15/2010
Last Dividend (on 12/08/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
JOHN MANIERI
Front Load Fee
1.20%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.20%
Expense Ratio
1.24%

Top Fund Holdings

Name Position Value % of Fund
114.00 k 11.96 m 9.73
68.00 k 10.68 m 8.69
36.80 k 10.60 m 8.62
118.00 k 10.21 m 8.31
22.40 k 8.88 m 7.23
37.00 k 5.33 m 4.33
57.00 k 4.78 m 3.89
31.00 k 4.65 m 3.78
94.00 k 4.05 m 3.29
42.00 k 3.89 m 3.16
Profile
BB Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.
Address
Swisscanto Fondsleitung AG
Bahnhofstrasse 9
8001 Zuerich
Switzerland
Phone
Tel: +41 58 344 49 00